𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The augmentation of lymphokine-activated killer activity following pulsing of human peripheral blood mononuclear cells with recombinant human interleukin-2

✍ Scribed by C. R. D. Carter; B. W. Hancock; R. C. Rees

Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
925 KB
Volume
35
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Induction of lymphokine-activated killer
Induction of lymphokine-activated killer cells from rat thymocytes using recombinant human interleukin-2
✍ Hisatoshi Imaya; Hiroshi Matsuura; Motoshige Kudo; Shozo Nakazawa πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 405 KB

Using a 4-h 51Cr release assay, we observed that thymocytes from Fischer strain rats incubated with recombinant human interleukin-2 (rhIL-2) developed cytotoxicity to YAC-1 lymphoma, 9L-glioma, and B-16 melanoma cells (effector/target ratio = 25/1). Induction of the lymphokine-activated killer (LAK)

Augmentation of cell number and LAK acti
Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2
✍ Peter M. Anderson; Fritz H. Bach; Augusto C. Ochoa πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 732 KB

A wide variety of human cancers currently have no effective treatment and are potential targets for lymphokine-activated killer (LAK) cellular immunotherapy. Relapsed acute lymphocytic leukemia (ALL) and neuroblastoma are two of the major therapeutic challenges in pediatric oncology today. However,